0
Episode64 of 335
Længde38M
SprogEngelsk
FormatKategori
This week Science in Action examines the evidence around the Trump Administration’s emergency use authorisation of convalescent plasma therapy for the treatment of Covid-19. Donald Trump described its US-wide roll-out as ‘historic’ but the majority of scientists and doctors disagree, questioning the scientific basis for the government’s decision. Roland Pease talks to Mayo Clinic’s Michael Joyner, the leader of the convalescent plasma therapy study on which the action was based. The Mayo Clinic trial involved a large number of patients but none of them were compared to Covid-19 patients who were not treated with convalescent plasma. Trials that incorporate that comparison are the only way to properly assess the therapy’s effectiveness. Roland talks to Martin Landray of the University of Oxford who is testing convalescent plasma therapy in the UK’s Recovery randomised control trial, and to medical ethicist Alison Bateman-House of the New York University Grossman School of Medicine.
We also talk to nanotechnologist Marc Miskin about the million-strong army of microscopic robots he’s creating in his lab at the University of Pennsylvania.
Presenter: Roland Pease Producer: Andrew Luck Baker
(Main image: New York lab tests serum from recovered covid-19 patients for possible therapy. Credit: Misha Friedman / Getty Images)
Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis
Lyt og læs så meget du har lyst til
Opdag et kæmpe bibliotek fyldt med fortællinger
Eksklusive titler + Mofibo Originals
Opsig når som helst
Om Mofibo
Jobs
nye app-funktioner
Investor Relations
Presse
Bæredygtighed
Tilgængelighedserklæring
Whistleblow
Søg
Bøger
Bogserier
Mofibo Originals
Podcasts
Forfattere
Indlæsere
Kategorier
Hjælpecenter
Abonnementer
Køb gavekort
Indløs gavekort
Indløs kampagnekode
Studierabat
Dansk
Danmark
Privatlivspolitik
Medlemsvilkår
Cookies
